Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortTwice-yearly bone-strengthening injection.Weekly tablet that strengthens bones.
Body systemHormones & BonesHormones & Bones
Drug classRANKL inhibitorsBisphosphonates
SupplyPrescription onlyPrescription only
Main usesOsteoporosis, Bone loss from hormone cancer treatment, Preventing fractures from bone metastasesOsteoporosis, Steroid-induced osteoporosis, Paget's disease
How it worksBlocks the signal that switches on bone-dissolving cells.Slows the cells that break bone down, so bone becomes denser.
Starts working——
Half-lifeAbout 26 daysOver 10 years in bone
Typical adult doseOsteoporosis: 60 mg under the skin every 6 months.70 mg once a week.
FormsPre-filled syringeTablet, Effervescent tablet, Oral solution
Common side effectsJoint and muscle pain, Back pain, EczemaHeartburn, Stomach pain, Muscle and bone aches
Serious side effectsLow calcium (severe in advanced kidney disease), Rebound spinal fractures if doses are missed, Jaw osteonecrosis (rare)Oesophageal ulcers, Jaw osteonecrosis (rare), Atypical thigh fractures (rare, long-term use)
Don't take if—Oesophageal problems (strictures, achalasia); Cannot sit or stand upright for 30 minutes; Low calcium; Severe kidney impairment (eGFR below 35)
Alcohol—Best to limit. Alcohol irritates the gullet and bones.
PregnancyUsually avoidedContraindicated.Usually avoidedNot used.
Breastfeeding—Usually avoidedAvoid.
In use since20101995
Brand namesUnited States: Prolia, Xgeva, Jubbonti (biosimilar)United Kingdom: Prolia, XgevaIndia: Prolia, DenosureUnited States: Fosamax, BinostoUnited Kingdom: FosamaxIndia: Osteofos, Densical
Legal status—United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeM05BX04M05BA04

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker